SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-18-000177
Filing Date
2018-03-02
Accepted
2018-03-02 09:53:49
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJON M. SAKODAJOSHUA MAKOWERNEA 15 GP, LLCNEA PARTNERS 15, L.P.NEW ENTERPRISE ASSOCIATES 15, L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- CASCADIAN THERAPEUTICS, INC. - SCHE cascadian-sch13da2_18017.htm SC 13D/A 423285
  Complete submission text file 0001072613-18-000177.txt   425441
Mailing Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Subject) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-84961 | Film No.: 18660205
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities IV, LLC (Filed by) CIK: 0001644965 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A